Find a Clinical Trial
Filter
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-01)
Breast cancer, Locally advanced and metastatic breast cancer
All genders
Recruiting now
Cancer Center
TAP Block and minimally invasive hysterectomy for pain control
Uterine cancer
Female
Recruiting now
Department of Obstetrics + Gynecology
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Breast Cancer Database
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy (CAMBRIA-1)
All genders
Recruiting now
Cancer Center
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast cancer
All genders
Recruiting now
Cancer Center
CABG HRV via WHOOP
Coronary artery disease
All genders
Recruiting now
Department of Anesthesiology + Perioperative Medicine
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast Cancer
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
HER2 Negative Breast Cancer
Breast cancer
All genders
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Multi-spectral imaging
Ovarian cancer
Female
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center